Paul I. Dargan

100.9k total citations
292 papers, 8.2k citations indexed

About

Paul I. Dargan is a scholar working on Toxicology, Emergency Medicine and Pharmacology. According to data from OpenAlex, Paul I. Dargan has authored 292 papers receiving a total of 8.2k indexed citations (citations by other indexed papers that have themselves been cited), including 140 papers in Toxicology, 118 papers in Emergency Medicine and 75 papers in Pharmacology. Recurrent topics in Paul I. Dargan's work include Forensic Toxicology and Drug Analysis (135 papers), Poisoning and overdose treatments (113 papers) and Cannabis and Cannabinoid Research (52 papers). Paul I. Dargan is often cited by papers focused on Forensic Toxicology and Drug Analysis (135 papers), Poisoning and overdose treatments (113 papers) and Cannabis and Cannabinoid Research (52 papers). Paul I. Dargan collaborates with scholars based in United Kingdom, United States and Australia. Paul I. Dargan's co-authors include David M. Wood, Alison L Jones, Shaun L. Greene, John R. H. Archer, S. Davies, Simon Hudson, J. Michael Ramsey, David W. Holt, Johann Gründlingh and Jenny Button and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Paul I. Dargan

288 papers receiving 7.8k citations

Peers

Countries citing papers authored by Paul I. Dargan

Since Specialization

Citations

This map shows the geographic impact of Paul I. Dargan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul I. Dargan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul I. Dargan more than expected).

Fields of papers citing papers by Paul I. Dargan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul I. Dargan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul I. Dargan. The network helps show where Paul I. Dargan may publish in the future.

Co-authorship network of co-authors of Paul I. Dargan

This figure shows the co-authorship network connecting the top 25 collaborators of Paul I. Dargan. A scholar is included among the top collaborators of Paul I. Dargan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul I. Dargan. Paul I. Dargan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Neurological aspects of drug misuse 2025 ·Practical Neurology ·Robin Howard, Paul Holmes, Paul I. Dargan	1
2	Analytically Confirmed Intentional Overdose of the Antidepressant Vortioxetine 2024 ·Journal of Medical Toxicology ·(unknown), (unknown), Simon Hudson, (unknown), Paul I. Dargan, David M. Wood	1
3	Comparison of Laboratory Confirmed Drugs in Acute Recreational Drug Toxicity Presentations to an Urban Hospital in London, UK, 2016/17 versus 2019/20 2024 ·Journal of Medical Toxicology ·(unknown), (unknown), John R. H. Archer, Albert H. Rowe, Simon Hudson, David M. Wood, Paul I. Dargan	1
4	Joint RCEM and NPIS best practice guideline: assessment and management of acute opioid toxicity in adults in the emergency department 2024 ·Emergency Medicine Journal ·(unknown), Rupinder Kaur Gill, Ruben Thanacoody, Chris Humphries, David M. Wood, Paul I. Dargan	1
5	ACMT Position Statement: End the Use of the Term “Excited Delirium” 2023 ·Journal of Medical Toxicology ·Andrew Stolbach, Paul I. Dargan, Howard A. Greller, Richard D. Hamilton, Kelly Johnson‐Arbor, Brian Murray, Daniel Ovakim, Laura M. Tormoehlen, Lewis S. Nelson, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	2
6	Determinants of Admission to Critical Care Following Acute Recreational Drug Toxicity: A Euro-DEN Plus Study 2023 ·Journal of Clinical Medicine ·Roberta Noseda, Matteo Franchi, Alberto Pagnamenta, (unknown), Alison M. Dines, Isabelle Giraudon, Fridtjof Heyerdahl, Florian Eyer, Knut Erik Hovda, Matthias E. Liechti, Óscar Miró, Odd Martin Vallersnes, Chris Yates, Paul I. Dargan, David M. Wood, Alessandro Ceschi	7
7	A Study Comparing Self-Reported Drugs and Results of An Immunoassay Test in Serum Samples in Patients Presenting to The Emergency Department with Acute Recreational Drug 2022 ·SHILAP Revista de lepidopterología ·(unknown), David M. Wood, (unknown), (unknown), (unknown), Paul I. Dargan	1
8	Accuracy of substance exposure history in patients attending emergency departments after substance misuse; a comparison with biological sample analysis 2022 ·Clinical Toxicology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Paul I. Dargan, Michael Eddleston, Jamie G. Cooper, (unknown), Rebecca Macfarlane, Liza Keating, (unknown), Simon Hudson, Simon H. L. Thomas	8
9	Linking in vitro and ex vivo CB1 activity with serum concentrations and clinical features in 5F-MDMB-PICA users to better understand SCRAs and their metabolites 2022 ·Archives of Toxicology ·(unknown), Simon Hudson, David M. Wood, (unknown), Paul I. Dargan, Christophe P. Stove	5
10	Machine Learning to Assist in Large-Scale, Activity-Based Synthetic Cannabinoid Receptor Agonist Screening of Serum Samples 2022 ·Clinical Chemistry ·(unknown), Dimitri Boeckaerts, Simon Hudson, (unknown), Annelies Cannaert, David M. Wood, (unknown), Bernard De Baets, Michiel Stock, Paul I. Dargan, Christophe P. Stove	9
11	Rhabdomyolysis related to acute recreational drug toxicity—A Euro-DEN study 2021 ·PLoS ONE ·W. James Waldman, (unknown), Alison M. Dines, David M. Wood, Chris Yates, (unknown), Knut Erik Hovda, Isabelle Giraudon, Paul I. Dargan, Jacek Sein Anand	12
12	Epidemiology, toxicokinetics and biomarkers after self-poisoning withGloriosa superba 2019 ·Clinical Toxicology ·(unknown), Indika Gawarammana, Fahim Mohamed, (unknown), Paul I. Dargan, (unknown), (unknown), Nicholas A. Buckley	6
13	Quantification of cocaine and cocaine metabolites in dried blood spots from a controlled administration study using liquid chromatography–tandem mass spectrometry 2018 ·Drug Testing and Analysis ·Lars Ambach, (unknown), Mark C. Parkin, Andrew T. Kicman, John R. H. Archer, David M. Wood, Paul I. Dargan, Christophe P. Stove	17
14	Analytical confirmation of synthetic cannabinoids in a cohort of 179 presentations with acute recreational drug toxicity to an Emergency Department in London, UK in the first half of 2015 2017 ·Clinical Toxicology ·(unknown), Simon Hudson, (unknown), Takahiro Yamamoto, (unknown), (unknown), Michelle Wood, Nele Sadones, Christophe P. Stove, Alison M. Dines, John R. H. Archer, David M. Wood, Paul I. Dargan	50
15	Microwave-assisted on-spot derivatization for gas chromatography–mass spectrometry based determination of polar low molecular weight compounds in dried blood spots 2016 ·Journal of Chromatography A ·Nele Sadones, (unknown), John R. H. Archer, David M. Wood, Paul I. Dargan, Luc Van Bortel, Willy E. Lambert, Christophe P. Stove	12
16	Psychosis associated with acute recreational drug toxicity: a European case series 2016 ·BMC Psychiatry ·Odd Martin Vallersnes, Alison M. Dines, David M. Wood, Chris Yates, (unknown), Knut Erik Hovda, Isabelle Giraudon, Paul I. Dargan	62
17	Novel psychoactive substances or ‘legal highs' 2015 ·British Journal of Hospital Medicine ·(unknown), Paul I. Dargan, David M. Wood	1
18	Acute Toxicity Associated with Analytically Confirmed Recreational use of Methiopropamine (1-(thiophen-2-yl)-2-methylaminopropane) 2014 ·Journal of Medical Toxicology ·(unknown), David M. Wood, Simon Hudson, John R. H. Archer, Paul I. Dargan	25
19	A modified low-cost colorimetric method for paracetamol (acetaminophen) measurement in plasma 2010 ·Clinical Toxicology ·Fathima Shihana, Kithsiri Dissanayake, Paul I. Dargan, Andrew Dawson	66
20	A case of hypomagnesaemia due to malabsorption, unresponsive to oral administration of magnesium glycerophosphate, but responsive to oral magnesium oxide supplementation 2001 ·Gut ·(unknown), Paul I. Dargan, Alan L. Jones, (unknown)	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact